Yahoo
OTC Markets OTCQB USD

Provectus Biopharmaceuticals, Inc. (PVCT)

0.0530 +0.0010 (+1.92%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Assets
697.5020 1,006.2590 1,448.8430 2,037.2460
Total Liabilities
7,000.2200 6,975.4840 9,042.1940 8,265.7560
Total Equity
-6,302.7180 -5,969.2250 -7,593.3510 -6,228.5100
Balance Sheet, Supplemental
Operating Lease Obligation Maturity Schedule Total
127.3040 -- 73.3770 117.7980
Total Debt
2,978.6970 3,184.7620 3,026.1910 2,184.6920
Net Debt
2,727.4060 2,877.3200 2,949.6150 2,163.0870
Working Capital
-6,329.5040 -5,998.7120 -7,652.0980 -6,293.1980
Invested Capital
-3,324.0210 -2,784.4630 -4,567.1600 -4,043.8180
Tangible Book Value
-6,302.7180 -5,969.2250 -7,593.3510 -6,228.5100
Common Equity Book Value
-6,313.8770 -5,973.3950 -7,616.0850 -6,250.6300
12/31/2022 - 1/15/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: